Boucher, Bradley, Pharm.D., FCCP, FCCM

Professor of Clinical Pharmacy and
Associate Dean, Strategic Initiatives and Operations

Office: 204 Pharmacy Building
Tel: (901) 448-4924


  1. Boucher, BA. Formularies, pharmacists, and influences on the decision-making process. Pharmacotherapy, 30 (6 Pt 2), 33S-4S, 2010.
  2. Boucher, BA. Formulary decisions: then and now. Pharmacotherapy, 30 (6 Pt 2), 35S-41S, 2010.
  3. Swanson, JM, Mueller, EW, Croce, MA, Wood, GC, Boucher, BA, Magnotti, LJ, Fabian, TC. Changes in pulmonary cytokines during antibiotic therapy for ventilator-associated pneumonia. Surg Infect (Larchmt), 11 (2), 161-7, 2010.
  4. Mueller, EW, Boucher, BA. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Surg Infect (Larchmt), 10 (6), 563-70, 2009.
  5. Czosnowski, QA, Wood, GC, Magnotti, LJ, Croce, MA, Swanson, JM, Boucher, BA, Fabian, TC. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy, 29 (9), 1054-60, 2009.
  6. Boucher, BA, Traub, O. Achieving hemostasis in the surgical field. Pharmacotherapy, 29 (7 Pt 2), 2S-7S, 2009.
  7. Boucher, BA. Attenuating the effects of cardiac arrest on hepatic drug metabolism: just chill out. Crit Care Med, 37 (1), 369-70, 2009.
  8. Swanson, JM, Wood, GC, Croce, MA, Mueller, EW, Boucher, BA, Fabian, TC. Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia. J Trauma, 65 (6), 1271-7, 2008.
  9. Brazeau, GA, Dipiro, JT, Fincham, JE, Boucher, BA, Tracy, TS. Your role and responsibilities in the manuscript peer review process. Am J Pharm Educ, 72 (3), 69, 2008.
  10. Mueller, EW, Croce, MA, Boucher, BA, Hanes, SD, Wood, GC, Swanson, JM, Chennault, SK, Fabian, TC. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. J Trauma, 63 (6), 1329-37; discussion 1337, 2007.
  11. Boucher, BA, Hannon, TJ. Blood management: a primer for clinicians. Pharmacotherapy, 27 (10), 1394-411, 2007.
  12. Boucher, BA, Wood, GC, Swanson, JM. Pharmacokinetic changes in critical illness. Crit Care Clin, 22 (2), 255-71, vi, 2006.
  13. Boucher, BA, Chyka, PJ, Fitzgerald, WL, Hak, LJ, Miller, DD, Parker, RB, Phelps, SJ, Wood, GC, Gourley, DR. A comprehensive approach to faculty development. Am J Pharm Educ, 70 (2), 27, 2006.
  14. Wood, GC, Mueller, EW, Croce, MA, Boucher, BA, Fabian, TC. Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients. Intensive Care Med, 32 (4), 599-603, 2006.
  15. Croce, MA, Swanson, JM, Magnotti, LJ, Claridge, JA, Weinberg, JA, Wood, GC, Boucher, BA, Fabian, TC. The futility of the clinical pulmonary infection score in trauma patients. J Trauma, 60 (3), 523-7; discussion 527-8, 2006.
  16. Wood, GC, Mueller, EW, Croce, MA, Boucher, BA, Hanes, SD, Fabian, TC. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surg Infect (Larchmt), 6 (2), 203-13, 2005.
  17. Mueller, EW, Hanes, SD, Croce, MA, Wood, GC, Boucher, BA, Fabian, TC. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma, 58 (1), 94-101, 2005.
  18. Croce, MA, Fabian, TC, Mueller, EW, Maish, GO, Cox, JC, Bee, TK, Boucher, BA, Wood, GC. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma, 56 (5), 931-4; discussion 934-6, 2004.
  19. Wood, GC, Hanes, SD, Boucher, BA, Croce, MA, Fabian, TC. Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive Care Med, 29 (11), 2072-6, 2003.
  20. Mueller, EW, Wood, GC, Kelley, MS, Boucher, BA, Fabian, TC, Croce, MA. The predictive value of preliminary bacterial colony counts from bronchoalveolar lavage in critically ill trauma patients. Am Surg, 69 (9), 749-55; discusiion 755-6, 2003.
  21. Wood, GC, Boucher, BA, Croce, MA, Fabian, TC. Lactobacillus species as a cause of ventilator-associated pneumonia in a critically ill trauma patient. Pharmacotherapy, 22 (9), 1180-2, 2002.
  22. Hanes, SD, Demirkan, K, Tolley, E, Boucher, BA, Croce, MA, Wood, GC, Fabian, TC. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis, 35 (3), 228-35, 2002.
  23. Wood, GC, Boucher, BA, Croce, MA, Hanes, SD, Herring, VL, Fabian, TC. Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy, 22 (8), 972-82, 2002.
  24. Wood, GC, Hanes, SD, Croce, MA, Fabian, TC, Boucher, BA. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis, 34 (11), 1425-30, 2002.
  25. Hanes, SD, Wood, GC, Herring, V, Croce, MA, Fabian, TC, Pritchard, E, Boucher, BA. Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg, 179 (6), 436-40, 2000.
  26. Boucher, BA. Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient. Am J Surg, 179 (2 Suppl 1), 45-50, 2000.